IN BRIEF: Positive QMS Opinion For Futura Medical's MED3000
IN BRIEF: Positive QMS Opinion For Futura Medical's MED3000
Read moreTue, 10th Nov 2009 09:22
IN BRIEF: Positive QMS Opinion For Futura Medical's MED3000
Read moreUK TRADING UPDATE SUMMARY: Brickability Recovering Well From Pandemic
Read more(Sharecast News) - Pharmaceutical company Futura Medical announced the completion of initial laboratory and optimisation work on a 'Dermasys' cannabidiol gel, dubbed 'CBD100', under the joint venture collaboration agreement with CBDerma Technology that was announced in September.
Read moreIN BRIEF: Futura Submits MED3000 Under EU Medical Device Regulation
Read moreFutura Medical Reports Limited Impact Of Covid-19 On Its Operations
Read more(Sharecast News) - Futura Medical updated the market on Wednesday, reporting that the impact of the Covid-19 pandemic on the company had been "limited" to date.
Read moreUK Shareholder Meetings Calendar - Next 7 Days
Read moreUK BROKER RATINGS SUMMARY: JPMorgan Raises Homeserve To Overweight
Read more(Sharecast News) - Futura Medical has filed for a further pre-submission meeting with the US Food and Drug Administration (FDA), it announced on Monday, following receipt of the complete and signed clinical study report for its phase 3 Study, 'FM57'.
Read moreFutura Files For Erectile Dysfunction Treatment Pre-Submission Meeting
Read moreFutura Optimistic Over Approvals For Erectile Dysfunction Treatment
Read moreUK Earnings, Trading Statements Calendar - Next 7 Days
Read moreFutura Pursues Regulatory Approval For Erectile Dysfunction Treatment
Read moreUK Shareholder Meetings Calendar - Next 7 Days
Read moreFutura Medical Raises GBP3.3 Million In Offer Backed By Lombard Odier
Read more